{{Rsnum
|rsid=11135910
|Gene=EBF2
|Chromosome=8
|position=26034626
|Orientation=plus
|GMAF=0.09229
|Gene_s=EBF2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 27.4 | 3.5
| HCB | 94.1 | 5.9 | 0.0
| JPT | 96.4 | 3.6 | 0.0
| YRI | 85.5 | 14.5 | 0.0
| ASW | 84.2 | 14.0 | 1.8
| CHB | 94.1 | 5.9 | 0.0
| CHD | 92.7 | 7.3 | 0.0
| GIH | 79.2 | 18.8 | 2.0
| LWK | 93.6 | 6.4 | 0.0
| MEX | 67.2 | 27.6 | 5.2
| MKK | 86.5 | 12.9 | 0.6
| TSI | 71.6 | 25.5 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535732
  |Trait=Prostate cancer
  |Title=Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
  |RiskAllele=A
  |Pval=8E-11
  |OR=1.11
  |ORtxt=[1.07-1.16]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}